Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HYR-PB21 local infiltration analgesia after hallux valgus osteotomy (phase III)
ChiCTR2500108222Phase 3Not yet recruiting
- Sponsor
- Beijing Tongren Hospital
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of HYR-PB21 in postoperative pain (3 arms), sponsored by Beijing Tongren Hospital. Primary endpoint: Area under the pain-time curve at rest (0–72 hours). Planned start Aug 2025; status: not yet recruiting.
02
Drugs
HYR-PB21
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2500108222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500108222.